Isoflurane Increases Neuronal Cell Death Vulnerability by Downregulating miR-214 by Yan, Hailiang et al.
City University of New York (CUNY) 
CUNY Academic Works 
Publications and Research City College of New York 
2013 







Beijing No.4 High School 
Kuo-Chieh Lee 
CUNY City College 
Hoau-Yan Wang 
CUNY City College 
See next page for additional authors 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/cc_pubs/751 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
Authors 
Hailiang Yan, Tao Xu, Hongfeng Zhao, Kuo-Chieh Lee, Hoau-Yan Wang, and Yan Zhang 
This article is available at CUNY Academic Works: https://academicworks.cuny.edu/cc_pubs/751 
Isoflurane Increases Neuronal Cell Death Vulnerability by
Downregulating miR-214
Hailiang Yan1,4., Tao Xu1,4., Hongfeng Zhao3, Kuo-Chieh Lee2, Hoau-Yan Wang2, Yan Zhang1,4*
1 State Key Laboratory of Biomembrane and Membrane Biotechnology, College of Life Sciences, Peking University, Beijing, China, 2 Department of Pharmacology,
Physiology and Neuroscience, Sophie Davis School of Biomedical Education/City University of New York Medical School, New York, New York, United States of America,
3 Beijing No.4 High School, Beijing, China, 4 Department of Urology, Peking University People’s Hospital, Beijing, China
Abstract
Since accumulating evidence suggests the application of anesthetics may increase the risk of Alzheimer’s disease (AD), we
investigated the cytotoxicity of inhaled general anesthesia in neurons and its underlying mechanism. Using primary
cultured rat hippocampal neurons as the study model, here we show that isoflurane increases vulnerability to intracellular or
extracellular amyloid b with or without serum deprivation. This isoflurane-induced effect is mediated by the downregulation
of miR-214 level that lead to an elevated expression of Bax, a prominent target for miR-214. We conclude that isoflurane
increases cell death in the presence of amyloid b by increasing Bax level through downregulating miR-214. Our data provide
a new insight for inhaled anesthetics toxicity and indicate a possible mechanistic link between anesthetic application and
neurodegenration in AD.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disease characterized by senile plaques and neurofibrillary tangles
in elderly [1]. With increasing number of older people worldwide
undergo surgery every year, accumulating evidence indicates the
association between anesthetic application and risk for AD.
Inhaled anesthetics can impair cognitive function especially in
aged individuals [2] and are associated with neuronal damage and
prolonged cognitive impairment [2,3,4,5,6,7,8,9,10,11,12,13].
While the age of AD onset has been linked to surgery history in
which inhaled anesthetics was used [14,15,16,17], there is also
evidence indicates that there is no correlation between the usage of
general anesthesia and AD [18]. Hence, current clinical data are
inconsistent in associating inhaled general anesthesia and risk for
AD.
Despite the conflicting clinical evidence on the risk of AD after
the usage of inhaled anesthetics, potential mechanisms responsible
for neuronal damage following inhaled anesthetia have been
suggested. In accord, some anesthetics promote protein misfolding
and aggregation, one of the mechanisms associating with cell
death in neurodegenerative diseases [12,19,20]. Inhaled anesthet-
ics are small haloalkanes or haloethers which can bind to
hydrophobic cavities of proteins [21,22,23] and have the ability
to increase the levels of small oligomers [24] which may include
amyloid b (Ab) peptides aggregates, the main component in senile
plaques. Isoflurane was shown to alter Ab precursor protein (APP)
processing, upregulate Ab production and induce apoptosis in H4
neuroglioma cells [12]. In APP-transfected H4 cells, desflurane
and hypoxia can also increase Ab production and caspase
activation [25]. Nuclear magnetic resonance (NMR) data indicate
that halothane, isoflurane and desflurane interact with Ab that
leads to its oligomerization [26,27]. Similarly, inhaled anesthesia
increased hyperphosphorylated tau, the primary component of
neurofibrillary tangles [28,29,30,31,32,33], although there is
evidence that the hypothermia, which is induced by anesthesia,
rather than anesthetics themselves, causes tau hyperphosphoryla-
tion [28]. Further, recent data show that intravenous anesthetic
propofol and inhaled anesthetic isoflurane both promote tau
hyperphosphorylation [34,35]. Taken together, our understanding
of how anesthetics increase neuronal cell death remains very
limited.
In our present study, we examined the underlying mechanism
reponsible for isoflurane-induced neuronal cell death when
combined with Ab or serum deprivation insults in cultured
primary rat neurons. We found that isoflurane decreased the level
of miR-214, which inhibited Bax activation. Therefore, isoflurane
enhanced Ab cytotoxicity through downregulating miR-214.
Results
Isoflurane Increased Ab and Serum Deprivation
Cytotoxicity
To further investigate the mechanisms of general anesthesia
induced cytotoxicity in cultured primary rat neurons, we treated
the cells in a closed chamber with incubation of 0.5% isoflurane
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for 3 hours. Simultaneously, the neurons were insulted with
intracellular Ab1-42 (iAb), extracellular Ab1-42 (eAb), or in
combination with serum deprivation (-S). In the un-insulted
neurons, isoflurane did not induce significant cell death 24 hours
after the treatment (Fig. 1A). In contrast, isoflurane markedly
increased cell death in neurons that were microinjected with Ab1-
42 peptide (iAb1-42) when compared with neurons with iAb1-42
alone (Fig. 1A). However, when neurons were treated with Ab1-42
peptide in culture medium (eAb1-42), isoflurane did not enhance
cell death compared with eAb1-42 alone (Fig. 1B). In contrast to
iAb1-42 or eAb1-42, iAb1-40 and eAb1-40 or the control reversed
peptides iAb42-1 and eAb42-1 did not alter the cell viability (Fig. 1A
and 1B). Application of isoflurane did not change the cell death in
the presence of iAb1-40, eAb1-40, iAb42-1 and eAb42-1 (Fig. 1A and
1B). When neurons were pre-incubated with isoflurane for 3 hours
and then insulted with either iAb1-42 or eAb1-42 peptide, isoflurane
pre-treatments significantly increased the cell death (Fig. 1C and
1D). We also examined the cytotoxicity of isoflurane in the
presence of serum deprivation. Our results showed that with
serum deprivation for 3 days, application of isoflurane for 3 hours
did not alter cell death levels (Fig. 1E). Isoflurane enhanced cell
death significantly only when iAb1-42 or eAb1-42 peptides were
combined with serum deprivation (Fig. 1E and 1F).
Bax Levels were Enhanced with Isoflurane Treatment
Pre-incubation of isoflurane potentiated the toxicity induced by
both iAb1-42 or eAb1-42 peptides in neurons (Fig. 1C and 1D). To
investigate the underlying mechanism responsible for the elevated
cytotoxicity of isoflurane treatment, we examined the protein
levels of Bax in the absence or presence of eAb1-42 peptide
application. Our Western blot data show that isoflurane markedly
increased total Bax levels in the absence and presence of eAb1-42
peptide (Fig. 2A). Using an antibody specifically detects the
activated Bax (6A7), our results showed that isoflurane also
increased activated Bax in the absence and presence of eAb1-42
(Fig. 2B). When neurons were microinjected iAb1-42 peptide
(Fig. 2C), the level of activated Bax was increased as indicated by
increased 6A7 staining in more neurons (Fig. 2D). The increased
activated Bax level is not mediated by the elevated Bax mRNA
since quantitative RT-PCR data indicated that there was no
significant difference in Bax mRNA levels in these treatment
groups (Fig. 2E). These data suggest that Bax protein levels might
be modified by anesthetics at post-transcriptional levels. To rule
out the possibility that isoflurane might decrease Bax degradation
to enhance Bax level, we microinjected Bax-EGFP fusion protein
expressing construct to primary neurons. A successful injection was
indicated by the presence of Dextran Texas Red (DTR) staining.
The cells were then treated with isoflurane for 3 hours
immediately after Bax-EGFP injection. At 12 hours after
anesthetics treatment, the numbers of EGFP positive cells versus
DTR positive cells were counted. Our results showed that there
was no significant difference between the treatment groups
compared with the control group (Fig. 2F), suggesting that
isoflurane did not affect Bax degradation.
Isoflurane Increased Bax Level through Downregulating
miR-214
To further investigate the mechanism responsible for isoflurane-
induced increase in Bax level, we performed microRNA array
assay in the neuronal extracts from control and isoflurane-treated
primary neurons. Among the microRNAs altered by isoflurane
application, miR-214 was significantly downregulated (Fig. 3B). In
accord with the notion that miR-214 level may be releated to Bax
abundance, Bax 39UTR was predicted to be a target of miR-214
(Fig. 3A). To this end, we transfected the neuroblastoma SH-Sy5y
cells with human Bax 39UTR regulated EGFP construct and co-
transfected with control, scramble microRNA, miR-214, mimic
miR-214, miR-214 inhibitor or mutant miR-214, respectively.
The transfection efficiency was indicated by RFP (Fig. 3C). Our
data showed that the relative number of EGFP positive cells in
RFP positive cells was decreased in the miR-214 and mimic miR-
214 transfected groups, but not in the scramble, miR-214 inhibitor
or mutant miR-214 groups (Fig. 3D), suggesting that miR-214
downregulated Bax expression. Similarly, Bax 39UTR regulated
luciferase assay showed miR-214 from 20 to 100 nM efficiently
decreased Bax expression (Fig. 3E). Time course of miR-214
indicated that maximal inhibition happened at 12–24 hours after
transfection, although the effect might last for at least 48 hours
(Fig. 3F).
To further confirm the role of miR-214 in regulating Bax level,
mutant Bax 39UTR was made by altering 2 nucleotides at WT
Bax 39UTR region. When mutant Bax 39UTR was co-transfected
into SH-Sy5y cells with either scramble or miR-214 sequence,
luciferase reportor assay showed no significant difference between
scramble and miR-214 transfected groups (Fig. 4A), suggesting
that miR-214 targeted Bax 39UTR specifically. To further proof
that miR-214 regulate Bax 39UTR selectively, microtubule-
associated protein 2 (MAP2) 39UTR was co-transfected with
scramble or miR-214 sequence. Our data prove no noticeable
different between scramble and miR-214 groups (Fig. 4A). Since
microRNAs bind to mRNAs at specific regions (binding domain,
BD), we made Bax 39UTR with double BD (2BD) and triple BD
(3BD). Our data showed that miR-214 inhibits Bax expression
increased propotionally with 2BD or 3BD construct (Fig. 4A), thus
confirming that miR-214 targeted Bax and downregulated its
expression. Western blot data showed that in SH-Sy5y cells, miR-
214 and mimic miR-214 decreased Bax level (Fig. 4B), while Bax
mRNA levels were not altered by miR-214 (Fig. 4C). These data
together indicate that miR-214 regulated Bax mRNA translation.
The relevance of isoflurane in vivo was tested in the rats treated
with inhaled 1% isoflurane for 3 hours and the levels of miR-214
were then measured in the whole brain tissues and CSF. Our data
indicated that following anesthetic treatment, miR-214 level was
decreased significantly in both brain tissues and CSF (Fig. 4D). To
assess whether AD affects the level of miR-214, we measured miR-
214 expression in the postmortem tissues from AD patients or age
matched controls. The RT-PCR results of hippocampal tissues
from 8 matched control-AD pairs with miR-214 showed that there
was no discernible difference detected between two diagnostic
groups (p = 0.38281, two-tailed Student’s t-test). There are no
significant correlation between miR-214 expression and age
(R2 = 20.69457) or postmortem intervals (R2 = 20.39699)
(Fig. 4E).
We then verified the effect of miR-214 on cell death in rat
primary neurons. Neurons were microinjected with miR-214,
mimic miR-214, miR-214 inhibitor or scramble sequence and
insulted with eAb1-42. The cells were treated with isoflurane for 3
hours and after 24 hours of treatment, the percentages of cell
death were measured. Our data showed that cell death was
significantly inhibited by miR-214 or mimic miR-214 injection,
and enhanced by miR-214 inhibitor injection (Fig. 4F). In parallel,
we microinjected Bax construct, Bax neutralizing antibodies 2D2
and 6A7 [36] and siRNAs to Bax. Our results indicated that while
Bax increased cell death significantly, its neutralizing antibodies
and siRNAs decreased cell death (Fig. 4F). Our data indicate that
miR-214 can reverse isoflurane-induced cell death in the presence
of eAb1-42, which can be mimicked by Bax suppression. Similarly,
the cell death induced by isoflurane with iAb1-42 and the
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Figure 1. Isoflurane increased Ab and serum deprivation cytotoxicity. (A) Isoflurane enhanced microinjected intracellular Ab (iAb)1-42, iAb1-40
and iAb42-1 peptide toxicity in primary rat neurons. Cell death levels were measured by TUNEL staining. (B) Isoflurane did not enhance extracellular Ab
(eAb)1-42, eAb1-40 and eAb42-1 peptide toxicity in primary rat neurons. (C) Pre-treatment of isoflurane for 3 hours increased iAb1-42 peptide toxicity. (D)
Pre-treatment of isoflurane for 3 hours increased eAb1-42 peptide toxicity. (E) Isoflurane enhanced the toxicity of the combination of iAb1-42 peptide
and serum deprivation (-S). (F) Isoflurane enhanced the toxicity of the combination of eAb1-42 peptide and serum deprivation (-S). Data represent
Means+SE (n = 200 for each group). **: p,0.01 compared with the control; ##: p,0.01 compared with the Ab group.
doi:10.1371/journal.pone.0055276.g001
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Figure 2. Bax was upregulated by isoflurane treatment. (A) Left panel: An example of western blot for total Bax (indicated by 2D2 antibody)
suggested that total Bax levels were increased by isoflurane in the absence or presence of eAb1-42 peptide. Right panel: Quantitative data showed
that isoflurane significantly enhanced total Bax levels. Data represent Means6SE (n = 3 repeats for each group). (B) Left panel: Representative images
showed that activated Bax (indicated by 6A7 antibody) was upregulated by isoflurane. Scale bar: 100 mm. Right panel: Quantitative data showed that
isoflurane significantly enhanced total bax levels. (C) Representative images showed microinjected neurons (indicated by injection marker dye
Alex488) with iAb1-42 peptide and activated Bax (6A7) staining. Scale bar: 50 mm. (D) Quantitative data showed that isoflurane significantly enhanced
total bax levels. (E) Quantitative RT-PCR results showed that there was no significant difference between isoflurane treatment groups on Bax mRNA.
(F) Quantitative data showed that isoflurane did not alter exogenous Bax levels at 12 hours after the treatment. Data represent Means6SE (n = 200
cells for each group). **: p,0.01 compared with the control. ##: p,0.01 compared with the Ab group.
doi:10.1371/journal.pone.0055276.g002
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combination of serum deprivation and Ab can also be reversed by
miR-214 (Fig. 4G–I), suggesting that miR-214 is indeed involved
in isoflurane cytotoxicity.
Discussion
The mechanisms leading to neurodegeneration in the neuro-
degenerative disease such as AD are of intense interest, among
which amyloid-b is generally considered to be a pathological
marker for AD. In accord with the notion that amyloid-b
promotes neurodegeneration, our previous studies demonstrate
that iAb1-42 and eAb1-42 can induced neuronal cell death through
activating Bax [36,37]. In the present study, we show that the
commonly used inhaled anesthetic, isoflurane, although do not
enhance cell death by themselves, increases vulnerability of the
pre-exposed neurons to both iAb1-42 and eAb1-42 insults.
Additionally, our data indicate that isoflurane increases both total
Bax and activated Bax levels. These data together suggest that
inhaled anesthetics do not directly alter cell viability but promote
cell vulnerability to Ab insult. Since isoflurane induces Bax
activation without showing significant cell death, our data suggest
that Bax activation by the inhaled anesthetics may have de-
stabilized mitochondria which in turn promote cell vulnerability to
amyloid-b insult and the eventual cell death. Interestingly,
isoflurane does not increase neuronal vulnerability to serum
deprivation alone although the underlying mechanism for this
differential effect remains obscured. Similar to our results, earlier
studies also support inhaled anesthetics may promote apoptosis. In
postnatal day 7 rat pups, combined application of isoflurane,
midazolam and nitrous oxide for 6 hours induces excessive
neuronal apoptosis throughout the brain such as the hippocampus
and cerebral cortex [7]. In cultured cells, isoflurane, isoflurane
with nitrous oxide, sevoflurane, desflurane with hypoxia all have
shown to induce apoptosis and increase Ab formation
[25,38,39,40,41].
It has been proposed that general anesthesia induces apoptosis
by suppressing neuronal activity, that in turn inhibits neurotrophic
factor secretion locally [42,43]. Caspase involvement in anesthe-
sia-induced apoptosis has also been implicated [25]. Although an
earlier report indicate that 2% isoflurane increases Bax mRNA
levels [44], we did not observe any discernible changes in Bax
mRNA following incubation with 0.5% isoflurane. Further
investigation of potential underlying mechanism reveals that
isoflurane decreases miR-214 level. miR-214 targets Bax 39UTR
and downregulates Bax expression by inhibiting its mRNA
translation. Therefore, isoflurane induces cytotoxicity and neuro-
nal cell death in the presence of Ab through downregulating miR-
214 (Fig. 5). This is the first time, to our knowledge, that inhaled
anesthetics induces cell death by regulating microRNAs is
reported. In addition to Bax expression that may be regulated
by miR-214, one single nucleotide polymophism (SNP) in
presenilin-1 (PS1) (rs63750082) was shown to create a potential
target site for miR-214 [45]. This may result in the downregu-
lation of PS1 by miR-214 and thereby reduces the production of
Ab and lessens AD pathology. However, our results in the
postmortem hippocampal tissues from 8 matched control-AD
pairs indicate that there is no discernible change in the miR-214
level in AD. Given that a higher Ab pathology in the AD brain,
our results predict that inhaled anesthetics would have hastened
neurodegeneration in AD subjects.
There is evidence that desflurane and isoflurane interact with
both nicotinic and muscarinic acetylcholine receptors (AchR) in a
dose-dependent manner [46]. Isoflurane treatment significantly
decreases the level of choline acetylase (ChAT), but not a7
nicotinic AchR in mouse brains [47]. Chronic application of
isoflurane also alters the level of muscarinic AchR in the
hippocampus [48]. Therefore, it is reasonable to hypothesize that
symptoms related to postoperative cognitive dysfunction are
possible consequence of inhaled anesthetics interacting with AchR
and suppressing central cholinergic transmission [49]. Further-
more, the role for the defected cholinergic function in AD
pathogenesis is well-supported by many studies [50], it is also
possible that inhaled anesthetics increase AD incidence through
inhibiting cholinergic function. Together with our data indicating
that isoflurane reduces miR-214 to increase cell death by
promoting Ab1-42 cytotoxicity, there data support the idea that
inhaled anesthetics may increase the risk of AD [33]. Most
importantly, our finding in this study suggests that therapies that
increase miR-214 may be used to reduce the neurotoxicity and
post-operative cognitive dsyfunction following the usage of inhaled
anesthetics, especially in AD patients.
Materials and Methods
Cell Culture
Primary neurons were cultured from new born Sprague Dawley
(SD) rat hippocampus. The protocol has been approved by the
regulations of Peking University Institutional Animal Care and
Use Committee (IACUC). In brief, the fresh hippocampal tissues
were dissociated with 0.25% trypsin (Invitrogen, Carlsbad, CA),
which was then inactivated by 10% decomplemented fetal bovine
serum (FBS, HyClone, Logan, UT). The mixture was triturated
through pipette to make a homogenous mixture. After filtering the
mixture through 70 mm sterilized filters, the flow-through was
centrifuged. The pellet was then washed once by phosphate
buffered saline (PBS, 0.14 M NaCl, 0.003 M KCl, 0.01 M
Na2HPO4, 0.002 M KH2PO4, pH7.2) and once by DMEM in
Earle’s balanced salt solution containing 0.225% sodium bicar-
bonate, 1 mM sodium pyruvate, 2 mM L-glutamine, 0.1%
dextrose, 1x antibiotic Pen-Strep (all from Invitrogen, Carlsbad,
CA) with 5% FBS. Cells were then plated on poly-L-lysine (Sigma,
St. Louis, MO) coated plates or glass coverslips at the density of
56104 cells/ml. Neurons were incubated at 37uC in DMEM
without phenol red with 5% FBS and with 5% circulating CO2.
Cytarabine was added to culture media 24 hours after plating at
10 mM to inhibit dividing cell growth. Medium was changed every
48 hours. SH-Sy5y cells were maitained in DMEM/F12 with 10%
FBS.
Cell and Animal Treatments
Ab peptides (Bachem, King of Prussia, PA) were dissolved in
sterile distilled water at 25 mM and immediately frozen at -20uC.
IAb peptides were delivered into neurons by microinjection at
Figure 3. Isoflurane decreased miR-214. (A) Sequence alignment of human and rat miR-214 and Bax 39UTR. (B) Levels of relative miR-214 in
isoflurane-treated primary rat neurons. (C) Representative images showed that in SH-Sy5y cells, the levels of reporter Bax 39UTR regulated EGFP
(green fluorescent) were regulated by miR-214 and its variants. RFP (red fluorescent) indicated the transfected cells. Scale bar: 50 mm. (D) Quantitative
data showed that miR-214 decreased Bax expression. M-miR-214: mimic miR-214; I-miR-214: miR-214 inhibitor. (E) miR-214 decreased Bax expression
in a dose-dependent manner. (F) The time course of miR-214 in suppression of Bax expression. Data represent Means6SE (n = 200 cells for each
group). **: p,0.01 compared with the control.
doi:10.1371/journal.pone.0055276.g003
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Figure 4. Isoflurane regulated cell death through miR-214. (A) miR-214 specifically acted on Bax 39UTR. (B) In SH-Sy5y cells, miR-214 inhibited
total Bax (indicated by 2D2 antibody) expression. (C) miR-214 did not alter Bax mRNA levels. (D) In the rats treated with inhaled isoflurane, miR-214
levels were decreased in the brain tissues and CSF. (E) The expression level of miR-214 in matched Alzheimer’s disease and control pairs. RT-PCR
results for hippocampal tissues from 8 matched control-AD pairs with miR-214 showed that there was no discernible difference detected between
two diagnostic groups (p = 0.38281, two-tailed Student’s t-test). (F) Left panel: in cultured primary rat neurons, microinjected miR-214 or mimic miR-
214 (M-miR-214) reversed cell death induced by isoflurane in the presence of eAb1-42. Right panel: Bax neutralizing antibodies (2D2 and 6A7) and Bax
siRNAs (RNAi-1, RNAi-2) blocked cell death induced by isoflurane in the presence of eAb1-42. (G) Left panel: microinjected miR-214 or mimic miR-214
(M-miR-214) reversed cell death induced by isoflurane in the presence of iAb1-42. Right panel: Bax neutralizing antibodies (2D2 and 6A7) and Bax
siRNAs (RNAi-1, RNAi-2) blocked cell death induced by isoflurane in the presence of iAb1-42. (H) Left panel: microinjected miR-214 or mimic miR-214
(M-miR-214) reversed cell death induced by isoflurane in the presence of eAb1-42 and serum deprivation (-S). Right panel: Bax neutralizing antibodies
(2D2 and 6A7) and Bax siRNAs (RNAi-1, RNAi-2) blocked cell death induced by isoflurane in the presence of eAb1-42 and serum deprivation (-S). (I) Left
panel: microinjected miR-214 or mimic miR-214 (M-miR-214) reversed cell death induced by isoflurane in the presence of iAb1-42 and serum
deprivation (-S). Right panel: Bax neutralizing antibodies (2D2 and 6A7) and Bax siRNAs (RNAi-1, RNAi-2) blocked cell death induced by isoflurane in
the presence of iAb1-42 and serum deprivation (-S). Data represent Means6SE (n = 200 cells for each group). **: p,0.01 compared with the control.
doi:10.1371/journal.pone.0055276.g004
Isoflurane Increases Neuron Vulnerability
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10 nM at the cytosolic area. EAb peptides were added to the
culture medium at 1 mM. For anesthetics treatment on cultured
cells, 0.5% isoflurane (l-chloro-2,2,2-trifluoroethyl difluoromethyl
ether) (Guoyao Group, Beijing, China) in humidified air with 5%
circulating CO2 was applied to a closed incubator 37uC for 3
hours. For anesthetics treatment on animals, SD rats (male,
around 250 g) were anesthetized with humidified 1% isoflurane in
30% O2 balanced by N2 for 3 hours in a closed chamber. After
exposure, the animals were returned to their cages. For
experiments described in Fig. 3, human miR-214, scramble
microRNA control, mimic miR-214, miR-214 inhibitor and
mutant miR-214 (59-ACAGACGGCACAGACAGGCAGU-39),
and for experiments described in Fig. 4F–I, rat miR-214, scramble
microRNA control, mimic miR-214, miR-214 inhibitor were all
purchased from Qiagen (Hilden, Germany). For experiments
described in Fig. 4A, several altered human Bax 39UTR sequences





WT and modified 39UTR sequences were cloned into pLenti-
Luc-UTR vector backbone (Abm, Richmond, BC, Canada).
MicroRNAs were transfacted into SH-Sy5y cells with Lipofecta-
mine 2000 (Invitrogen, Carlsbad, CA) and microinjected into
primary rat neurons. MicroRNA levels were measured by
CapitalBio (Beijing, China) microarray service with 3 repeats by
using GeneChip microRNA 2.0 (Affymetrix). miR-214 in the
brain tissue and CSF was measured by TaqMan MicroRNA assay
kit for rno-miR-214 according to the manufacturer’s instruction
(Life Technologies Corp. Shanghai, China). All Bax siRNAs
(Qiagen, Hilden, Germany) were diluted into 5 nM before
injection described by the manufacturer. The silencing efficiency
and off-target effects of all siRNAs were verified by Qiagen.
Microinjection
Thin-walled Borosilicate glass capillaries (outer diame-
ter = 1.0 mm, inner diameter = 0.5 mm) with microfilament
(MTW100F-4, World Precision Instrument, Sarasota, FL) were
pulled with a Flaming/Brown Micropipette Puller (P-97, Sutter,
Novato, CA) to obtain injection needles with a tip diameter of
,0.5 mm. Microinjections were performed in the cytosol of each
cell using the Eppendorf Microinjector FemtoJet and Eppendorf
Micromanipulator (Eppendorf, Hamburg, Germany). Neurons
were injected with 25 fl/shot at an injection pressure of 100 hPa, a
compensation pressure of 50 hPa, and an injection time of 0.1
seconds, at the soma areas. The solutions were injected at the
indicated concentrations with 100 mg/ml dextran Texas Red
(DTR, MW: 3000, Molecular Probes, Eugene, OR) or Alex488
(Molecular Probes, Eugene, OR) as fluorescent markers to
recognize the injected cells. Approximately 90% neurons survive
the injections for at least 16 days [51].
Measurement of Neuronal Cell Death
Cells were fixed in fresh 4% paraformaldehyde, 4% sucrose in
PBS for 20 minutes at room temperature and permeablized in
0.1% Triton X-100, 0.1% sodium citrate in PBS for 2 minutes on
ice. Terminal deoxynucleotidyl transferase-biotin dUTP nick-end
labeling (TUNEL) staining was performed using the in situ cell
death detection kit I as described by the manufacturer (Roche,
Quebec, Canada). The coverslips were then washed once in
distilled water for 5 minutes and mounted on glass slides to be
observed under a fluorescence microscope. For the non-injected
cells, the percentage of cell death was determined by the ratio of
the number of TUNEL-positive cells over the total of 100 cells in
one count. The average of 5 counts was calculated as the
percentage of neuronal cell death in a certain treatment. For the
injected cells, the percentage of cell death was determined as the
ratio of the number of DTR-TUNEL-double-positive cells over
the total number of DTR-positive cells.
Immunostaining
Cells were permeablized in PBS-Triton at 4uC, blocked 10%
donkey serum at room temperature, followed by incubation with
anti-activated Bax antibody (6A7, R&D, Minneapolis, MN, 1:200)
at 4uC for 24 hours. Cy2 or Cy3-conjugated donkey anti-rabbit
antibody was applied as the secondary antibody. The nuclei were
then staining by Hoechst 33258 (1 mg/ml, Sigma, St. Louis, MI)
for 15 minutes in dark. The coverslips were mounted with
ImmunonTM mounting medium (Shandon, Pittsburgh, PA) onto
glass slides the results were analyzed by using fluorescence
microscope (Olympus BH2-RFCA, Olympus, Tokyo, Japan) with
digital camera (Olympus DP70 Digital Microscope Camera,
Olympus, Tokyo, Japan).
Postmortem Tissues
This study protocol conformed to the Helsinki (the 4th
amendment) as reflected in a prior approval by the institution’s
human research committee. Postmortem brain tissues (frontal
cortex) from patients with clinically diagnosed sporadic AD (n = 8,
age range = 56–91, mean: 71.164.7) and control tissues from
normal, age-matched, neurologically normal (n = 8, age
range = 55–99, mean: 72.065.7) individuals were obtained from
the University of Pennsylvania Brain Tissue Resource Center. The
postmortem time intervals for collecting these brains were # 15 hr
(mean postmortem intervals for collection of AD and control brain
samples were 9.661.5 hr and 9.661.8 hr, respectively). There
were no discernible differences between diagnostic groupa in age
(p = 0.90141) and postmortem interval (p = 0.98219).
All cases of AD dementia studied met clinical criteria for that
disorder specified by NINCDS-ADRDA [52] as determined in
consensus conferences after review of medical records, direct
clinical assessments, and interviews of care providers. Clinical
diagnosis requires that an individual showed clear cognitive
decline from his or her previous levels as verified in tests of
memory and in least one other cognitive domain (e.g., perceptual
speed). The diagnoses were confirmed by postmortem examina-
tion of neuritic plaque densities in midfrontal gyrus (dorsolateral
prefrontal cortex), superior+inferior temporal gyrus, inferior
parietal gyrus, hippocampus, and substantia nigra as specified by
the Consortium to Establish a Registry for AD (Mirra et al., 1991).
The final diagnoses were consistent with Braak scores for
neurofibrillary tangle pathology as recommended by the NIA-
Reagan Institute consensus on diagnosis of AD [53]. All
Figure 5. Schematic drawing for isoflurane cytotoxicity mech-
anism.
doi:10.1371/journal.pone.0055276.g005
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postmortem tissues were identified by an anonymous identification
number, and experiments were performed as a best matched pair
without knowledge of clinical information.
Tissue Samples and Extraction
Frozen hippocampal formation was lysed in QIAzol lysis
reagent (Qiagen, Hilden, Germany) and homogenized with
Kontes pestle. Extraction of RNA was performed by using
miRNeasy kit (cat# 217004, Qiagen, Hilden, Germany). Briefly,
for 700 l of QIAzol, 140 l of chloroform was added and mixed for
15 seconds. After 3 minutes incubation at room temperature, the
samples were centrifuged at 12,000 g (4uC) for 15 min. The upper
aqueous layer containing RNA was transferred to another
microcentrifuge tube for RNA extraction. Total RNA was
solubilized in nuclease free water (cat# AM9932, Ambion)
purified using RNeasy Mini columns (Qiagen, Hilden, Germany)
according to manufacturer instructions. Nucleic acid concentra-
tions were determined by Qubit fluorometer (cat# Q32857,
Invitrogen, Carlsbad, CA) and samples were stored at 80uC.
Real Time PCR (RT-PCR)
For brain tissues, RT-PCR was performed using the QIAgen
MicroRNA Reverse Transcription kit (cat# 218161, Miscript II
RT). cDNA concentrations were determined by Qubit fluorom-
eter. QIAgen Miscript SYBR Green PCR kit (cat # 218073) was
used to detect miR-214 expression. Forward primer Micro RNA
214, 59-acagcaggcacagacaggcagu-39, was purchased from QIAgen
(cat# MS00031605). The QIAgen small nucleolus RNA primer
(RNU 6 cat# MS00031605) was used to detect reference gene. All
real time PCR reactions were performed on iCycler Real Time
PCR System (BioRad, Hercules, CA) according to manufacturer’s
recommendation. MicroRNA quantity in each individual sample
was calculated by the delta Ct method.
For RT-PCR with cellular extracts, cells were harvested and
total RNA was isolated with TRIGene reagent (GenStar
BioSolutions Co., Ltd., Beijing, China). Total RNA (2 mg) were
reversely transcribed using TransScript II First-Strand cDNA
Synthesis SuperMix (Beijing TransGen Biotech Co., Ltd., Beijing,
China). Real-time PCRs were done by using TransStart Green q
PCR SuperMix UDGTM (Beijing TransGen Biotech Co., Ltd.,
Beijing, China). Sequences of primers for Bax used were as
following: forward: (59-GCAGAGGATTGCTGATG-39); and
reverse: (59-CTCAGCCCATATTCTTCCAG-39). Real-time
PCR quantifications were run in triplicate for each sample and
the average were determined. In order to use the comparative Ct
method for relative quantification, the amplification efficiency of
target and housekeeping gene must be approximately equal.
Quantification was done using the comparative Ct method,
expression levels for the target gene was normalized to the
GAPDH of each sample [22gCt = 22(Ct(target gene)2Ct(GAPDH))].
Amplification was done for 45 cycles at 95uC for 30 s, 59uC for 30
s, 72uC for 30 s, 95uC for 1 min, 59uC for 30 s and 95uC for 30 s.
Western Blots
Neuronal proteins were extracted in the cell lysis buffer (50 mM
Tris, pH8.0, 150 mM NaCl, 1% NP-40, 0.1% SDS) and protein
concentrations were measured by bicinchoninic acid (BCA) assay
(Pierce, Rockford, IL). Protein extracts were denatured at 100uC
for 5 minutes and separated on 15% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) at 70 volts for
about 2 hour. Proteins were transferred to Immobilon-PTM
polyvynilidene fluoride (PVDF) membrane (Millipore, Billerica,
MA) at 100 milliamps for 2 hours. The membrane was blocked
with 5% non-fat milk in Tris buffered saline (TBS) with 0.1%
tween20 (TBS-T) at room temperature for 1 h. Anti-Bax (2D2,
R&D, Minneapolis, MN) and GAPDH (Sigma, St. Louis, MO)
antibodies were diluted at 1:1000 for Western blots as primary
antibodies. After 3 washes of 10 minutes each with TBS-T, goat
anti-mouse or anti-rabbit IgG conjugated with horseradish
peroxidase (HRP) was added in a dilution of 1:2500 as the
secondary antibody. The secondary HRP was detected by
enhanced chemiluminescence. Optical density was analyzed by
BioRad ChemiDox (BioRad, Hercules, CA). The relative density
was calculated by the total absolute density of Bax/GAPDH.
Statistical Evaluation
Statistical significance was assessed by one-way analysis of
variances (ANOVA). The Sheffé’s test was applied as a post hoc for
the significant difference shown by ANOVAs. A p value of less
than 0.05 was used as an indicative of statistical significance.
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